GRIP2 min read
Jean Hurley19 min listen
GRIP2 min read
Our in-brief roundup of notable stories from the last week.
GRIP2 min read
Our in-brief roundup of notable stories from the last week.
GRIP1 min read
The North Carolina insurer admitted to misusing proprietary software and an AI platform to enroll seniors without consent.
Vlada Gurvich4 min read
Our in-brief roundup of notable stories from the last week.
GRIP2 min read
The FDA has unveiled FDA PreCheck, a two-phase program designed to speed approvals and boost regulatory certainty for US drug manufacturing projects.
Vlada Gurvich3 min read
Japan’s reciprocal tariff agreement with the US underscores how fragile trade commitments can create layered compliance risk.
Vlada Gurvich4 min read
Whistleblower alleged Caremark reported higher costs of drugs to the government than it paid pharmacies for dispensing Medicare Part D drugs.
Julie DiMauro2 min read
OpenBind consortium, new Centre for AI-driven innovation, and supercomputer funding all intended to help drive drug R&D
Thomas Hyrkiel, Jean Hurley3 min read